Johnson & Johnson’s One-Dose COVID Vaccine Promising in Early Trial
WEDNESDAY, Jan. 13, 2021 — A single-shot COVID-19 vaccine from Johnson & Johnson has shown very strong results in early clinical trials, potentially providing a significant boost to U.S. vaccination efforts. The vaccine produced an immune response of all 805 clinical trial participants within two months of inoculation, according toContinue Reading










